bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2019: S A J J M A M F J
2018: D N O S

 
  Other news for:
Alzheimer Disease
 Resources from HONselect
'Miracle' Young Blood Infusion Treatments Unproven, Potentially Harmful: FDA

By E.J. Mundell

TUESDAY, Feb. 19, 2019 (HealthDay News) -- They're often called "vampire" treatments, in which people undergo infusions of a young donor's blood plasma to treat everything from aging to Alzheimer's and multiple sclerosis.

But these expensive "fountain of youth" therapies are unproven and potentially unsafe, the U.S. Food and Drug Administration warned on Tuesday.

"Simply put, we're concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies," FDA Commissioner Dr. Scott Gottlieb said in an agency news release. "Such treatments have no proven clinical benefits for the uses for which these clinics are advertising them and are potentially harmful."

According to the FDA, the use of plasma infusion therapies is on the rise across the United States, often costing thousands of dollars per treatment. The service is being offered by businesses in many states to allegedly treat conditions ranging from normal aging and memory loss to serious disorders such as dementia, Parkinson's disease, multiple sclerosis, Alzheimer's disease, heart disease and post-traumatic stress disorder (PTSD).

Plasma -- the liquid portion of blood -- contains proteins that help clot blood and can be used to treat bleeding and clotting problems. Plasma can benefit patients with severe injuries and those whose blood can't clot due to medications or certain illnesses.

But even under such approved uses, plasma carries risks that include allergic reactions, transfusion-associated circulatory overload, transfusion-related acute lung injury and infectious disease transmission, the FDA said.

"We have significant public health concerns about the promotion and use of plasma for these purposes," Gottlieb said. "There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat, or prevent these conditions, and there are risks associated with the use of any plasma product.

"Treatments using plasma from young donors have not gone through the rigorous testing that the FDA normally requires in order to confirm the therapeutic benefit of a product and to ensure its safety," he explained. "As a result, the reported uses of these products should not be assumed to be safe or effective."

In one example, HuffPost conducted its own investigation into Ambrosia, a startup company offering young plasma services it claims can ease a wide range of ailments.

Jesse Karmazin, Ambrosia's 34-year-old founder, said he was charging customers in multiple states $12,000 for treatments during which they received 2 liters of young plasma.

According to HuffPost, Karmazin said he didn't feel FDA approval of his own study of the merits of young plasma therapy was necessary -- and the results of the study have never been released.

Nevertheless, Karmazin told the U.K. newspaper The Times, "I'm not really in the camp of saying this will provide immortality, but I think it comes pretty close."

But the FDA believes that as with many experimental procedures, it's "buyer beware" when it comes to plasma infusions.

The agency's advice: Anyone considering using plasma for these unapproved uses should talk with their doctor first.

More information

The American Red Cross explains types of blood donations.

SOURCES: U.S. Food and Drug Administration, news release, Feb. 19, 2019, HuffPost, Feb. 19, 2019; The Times (U.K.), Aug. 20, 2017

Copyright © 2019 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=742911

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Plasma
Therapeutics
Blood
Tissue Donors
Wounds and Injuries
Multiple Sclerosis
Risk
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact